Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Digirad Imaging Systems is a commercial diagnostic imaging and medical device business focused on solid-state nuclear imaging systems and related support services. The company markets portable and office-based gamma camera and SPECT systems for nuclear cardiology and general nuclear medicine, including the Cardius XPO, Ergo, and X-ACT+ product lines. In addition to equipment sales, leasing, rental, OEM parts, and field service, the broader Digirad brand also supports point-of-care and mobile diagnostic imaging workflows for healthcare providers. The business is now operated as part of Catalyst MedTech following the 2023 acquisition of Digirad Health, and it remains active under the Digirad brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digirad Imaging Systems.